Our findings mirror recently published results where DNA replication and IGF1R signaling were identified as key dependencies unique to pediatric tumor types, further suggesting that drug targets within these pathways could be useful therapeutic approaches in pediatric cancer [2, 19]. This evidence concerns the gene IGF1R and neoplasm.